ASR Vermogensbeheer’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28M Sell
237,166
-40,381
-15% -$4.66M 0.29% 67
2026
Q1
$33.2M Buy
277,547
+3,758
+1% +$493K 0.39% 57
2025
Q4
$37.3M Sell
273,789
-5,849
-2% -$841K 0.43% 44
2025
Q3
$41.2M Buy
279,638
+14,977
+6% +$2.08M 0.5% 37
2025
Q2
$34.2M Buy
264,661
+1,700
+0.6% +$206K 0.44% 45
2025
Q1
$31.4M Buy
+262,961
New +$32.6M 0.47% 45

Other funds holding XYL

ASR Vermogensbeheer's XYL Position: Q2 2026 in Review

ASR Vermogensbeheer reduced its Xylem (XYL) stake by 15% in Q2 2026, selling an estimated $4.66M and leaving 237,166 shares worth $28M. The position accounts for 0.29% of the portfolio, ranked #67.

ASR Vermogensbeheer first reported a position in XYL in Q1 2025 and has held it in 6 quarters since. The position peaked at $41.2M in Q3 2025. 1,092 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • ASR Vermogensbeheer held 237,166 shares of Xylem worth $28M as of Q2 2026.
  • ASR Vermogensbeheer sold 40,381 Xylem shares in Q2 2026, an estimated $4.66M.
  • Xylem made up 0.29% of ASR Vermogensbeheer's portfolio in Q2 2026, its #67 holding.
  • ASR Vermogensbeheer first reported a position in Xylem in Q1 2025 and has held it in 6 quarters since.
  • ASR Vermogensbeheer's Xylem position peaked at $41.2M in Q3 2025.
  • 1,092 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on ASR Vermogensbeheer's 13F filing for Q2 2026, filed 20 Jul 2026.